Profiling of differentially expressed genes in human uterine leiomyomas

International Journal of Gynecological Cancer

Volumn 15, Issue 1, 2005, Pages 146-154

  Lee, E J ^a   Kong, G ^b   Lee, S H ^a   Rho, S B ^a   Park, C S ^a   Kim, B G ^a   Bae, D S ^a   Kavanagh, J J ^c   Lee, Je Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cDNA microarray; Immunohistochemistry; RT PCR; Uterine leiomyoma

Indexed keywords

COMPLEMENTARY DNA;

ADULT; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC VARIABILITY; GYNECOLOGIC DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MOLECULAR GENETICS; MYOMETRIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; UNINDEXED SEQUENCE; UTERUS MYOMA;

ADULT; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEIOMYOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UTERINE NEOPLASMS;

EID: 13244255290     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891x.2005.15016.x     Document Type: Article

References (33)

1. Marshall LM, Spiegelman D, Barbieri RL et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967-73.
2. Lepine LA, Hillis SD, Marchbanks PA et al. Hysterectomy surveillance - United States, 1980-1993. MMWR CDC Surveill Summ 1997;46:1-15.
3. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970;107:1168-73.
4. Xing YP, Powell WL, Morton CC. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet Cytogenet 1997;98:69-74.
5. Fejzo MS, Yoon SJ, Montgomery KT et al. Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 1995;26:265-71.
6. Matsunami K, Imai A, Ohno T, Tamaya T. Suppression of growth-promoting activity in extract from human uterine cancer by cyclic AMP-mediated mechanism. Res Commun Chem Pathol Pharmacol 1991;73:371-4.
7. Ohmichi M, Kioke K, Nohara A et al. Oxytocin stimulate mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 1995;136:2082-7.
8. Bajo A, Carrero I, Hristov RL et al. Impairment of adenylate cyclase activity and G-proteins in human uterine leiomyoma. Tissue Cell 2000;32:399-404.
9. Chegini N, Verala J, Luo X, Xu J, Williams RS. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 2002;10:161-71.
10. Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 2003;209:9-16.
11. Tsibris JC, Segars J, Coppola D et al Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 2002;78:114-21.
12. Vollenhoven BJ, Herington AC, Healy DL. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 1993;76:1106-10.
13. Gloudemans T, Prinsen I, Van Unnik JA, Lips CJ, Den Otter W, Sussenbach JS. Insulin-like growth factor gene expression in human smooth muscle tumors. Cancer Res 1990;50:6689-95.
14. Tricoli JV, Rall LB, Karakousis CP et al Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986; 46:6169-73.
15. Hoppener JW, Mosselman S, Roholl PJ et al Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours. EMBO J 1988;7:1379-85.
16. Ogawa O, Eccles MR, Szeto J et al Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-51.
17. Yee D, Cullen KJ, Paik S et al. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 1988;48:6691-6.
18. Sohda T, Yun K, Iwata K, Soejima H, Okumura M. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab Invest 1996;75:307-11.
19. Van der Ven LT, Roholl PJ, Gloudemans T et al Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues. Br J Cancer 1997;75:1631-40.
20. Lau LF, Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 1985;4:3145-51.
21. Lau LF, Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 1987;84:1182-6.
22. Brunner A, Chinn J, Neubauer M, Purchio AF. Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol 1991;10:293-300.
23. Sampath D, Zhu Y, Winneker RC, Zhang Z. Aberrant expression of Cyr61, a member of the CCN (CTGF/ Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 2001;86:1707-15.
24. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002;21:8178-85.
25. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999;248:44-57.
26. Huang RP, Fan Y, de Belle I et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997;72:102-9.
27. Hao MW, Liang YR, Liu L, Wu MY, Yang HX. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cells lines. World J Gastroenterol 2002;8:203-7.
28. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res 1998;58:2461-8.
29. Kobayashi D, Yamada M, Kamagata C et al. Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res 2002; 22:3963-70.
30. Xie L, Xu L, He Z et al. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array. J Cancer Res Clin Oncol 2000;126:400-6.
31. Pambuccian CA, Oprea GM, Lakatua DJ. Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display. Gynecol Oncol 2002;84:431-6.
32. Wu X, Blanck A, Norstedt G, Sahlin L, Flores-Morales A. Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium. Mol Hum Reprod 2002;8:246-54.
33. Tsibris JC, Maas S, Segars JH et al. New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2. Biochem Biophys Res Commun 2003;312:249-54.